These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 16893691)
1. A potential generic downstream process using Cibracon Blue resin at very high loading capacity produces a highly purified monoclonal antibody preparation from cell culture harvest. Riske F; Smith M; Menon M; Goetschalck S; Goidsenhoven IV; Krul A; Pimpaneau V; Renaers I; Van Tichelt N; Van Houdt K; Hayes M; Lawrence C; Bigelow R; Schroeder J J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):108-15. PubMed ID: 16893691 [TBL] [Abstract][Full Text] [Related]
2. Comparison of standard and new generation hydrophobic interaction chromatography resins in the monoclonal antibody purification process. Chen J; Tetrault J; Ley A J Chromatogr A; 2008 Jan; 1177(2):272-81. PubMed ID: 17709111 [TBL] [Abstract][Full Text] [Related]
3. Process-scale purification from cell culture supernatants: monoclonal antibodies. Ostlund C; Borwell P; Malm B Dev Biol Stand; 1987; 66():367-75. PubMed ID: 3108053 [TBL] [Abstract][Full Text] [Related]
4. Host cell protein clearance during protein A chromatography: development of an improved column wash step. Shukla AA; Hinckley P Biotechnol Prog; 2008; 24(5):1115-21. PubMed ID: 19194921 [TBL] [Abstract][Full Text] [Related]
5. Improving affinity chromatography resin efficiency using semi-continuous chromatography. Mahajan E; George A; Wolk B J Chromatogr A; 2012 Mar; 1227():154-62. PubMed ID: 22265178 [TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of recombinant human anti-HAV monoclonal antibody. Wei JS; Tao R; Sun WW; Jia Q; Li C; Liang MF Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):257-61. PubMed ID: 15969118 [TBL] [Abstract][Full Text] [Related]
7. Exploitation of the adsorptive properties of depth filters for host cell protein removal during monoclonal antibody purification. Yigzaw Y; Piper R; Tran M; Shukla AA Biotechnol Prog; 2006; 22(1):288-96. PubMed ID: 16454522 [TBL] [Abstract][Full Text] [Related]
9. DNA spike studies for demonstrating improved clearance on chromatographic media. Butler MD; Kluck B; Bentley T J Chromatogr A; 2009 Oct; 1216(41):6938-45. PubMed ID: 19733359 [TBL] [Abstract][Full Text] [Related]
10. Purification of humanized monoclonal antibody by hydrophobic interaction membrane chromatography. Ghosh R; Wang L J Chromatogr A; 2006 Feb; 1107(1-2):104-9. PubMed ID: 16388812 [TBL] [Abstract][Full Text] [Related]
11. Process and product monitoring of recombinant DNA-derived biopharmaceuticals with high-performance capillary electrophoresis. Sunday BR; Sydor W; Guariglia LM; Obara J; Mengisen R J Capill Electrophor Microchip Technol; 2003; 8(5-6):87-99. PubMed ID: 15369173 [TBL] [Abstract][Full Text] [Related]
12. Performance of hexamer peptide ligands for affinity purification of immunoglobulin G from commercial cell culture media. Naik AD; Menegatti S; Gurgel PV; Carbonell RG J Chromatogr A; 2011 Apr; 1218(13):1691-700. PubMed ID: 21176908 [TBL] [Abstract][Full Text] [Related]
13. Serum preparation and methods for the large-scale production of IgG monoclonal antibody. Zeng QS; Takeyama H; Kanda S; Irie RF Hum Antibodies Hybridomas; 1994; 5(1-2):75-80. PubMed ID: 7858185 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody: high density culture of hybridoma cells and downstream processing for IgG recovery. Kundu PK; Prasad NS; Datta D Indian J Exp Biol; 1998 Feb; 36(2):125-35. PubMed ID: 9754040 [TBL] [Abstract][Full Text] [Related]
15. Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics. Strauss DM; Lute S; Tebaykina Z; Frey DD; Ho C; Blank GS; Brorson K; Chen Q; Yang B Biotechnol Bioeng; 2009 Oct; 104(2):371-80. PubMed ID: 19575414 [TBL] [Abstract][Full Text] [Related]
16. Affinity purification of IgG monoclonal antibodies using the D-PAM synthetic ligand: chromatographic comparison with protein A and thermodynamic investigation of the D-PAM/IgG interaction. D'Agostino B; Bellofiore P; De Martino T; Punzo C; Rivieccio V; Verdoliva A J Immunol Methods; 2008 Apr; 333(1-2):126-38. PubMed ID: 18313690 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of new affinity chromatography resins for polyclonal, oligoclonal and monoclonal antibody pharmaceuticals. Ishihara T; Nakajima N; Kadoya T J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(23):2141-4. PubMed ID: 20591751 [TBL] [Abstract][Full Text] [Related]
18. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system. Tang YJ; Ohashi R; Hamel JF Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696 [TBL] [Abstract][Full Text] [Related]
19. Fast and scalable purification of a therapeutic full-length antibody based on process crystallization. Smejkal B; Agrawal NJ; Helk B; Schulz H; Giffard M; Mechelke M; Ortner F; Heckmeier P; Trout BL; Hekmat D Biotechnol Bioeng; 2013 Sep; 110(9):2452-61. PubMed ID: 23532914 [TBL] [Abstract][Full Text] [Related]
20. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes. Shukla AA; Jiang C; Ma J; Rubacha M; Flansburg L; Lee SS Biotechnol Prog; 2008; 24(3):615-22. PubMed ID: 18410156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]